Geraghty James A

Geraghty James A is listed in filings as Director at Voyager Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 30, 2025, including purchase activity. Recent filings connect the profile to Voyager Therapeutics, Inc. (VYGR), Pieris Pharmaceuticals, Inc. (PIRS), and Fulcrum Therapeutics, Inc. (FULC). The current snapshot covers public activity from Jun 18, 2024 to Jun 30, 2025. Reported amounts are shown as $78.7K to $210.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.